CNE100003RM8
CNE100003RM8
ZHEJIANG ORIENT GENE BIOTECH CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 947.379.904 | 827.916.212 | 14.4% |
| Cost of Revenue | 560.899.414 | 565.129.984 | 0.7% |
| Gross Profit | 386.480.489 | 262.786.228 | 47.1% |
| 833.367.590 | 895.537.772 | 6.9% | |
| Operating Income | -446.887.101 | -632.751.544 | 29.4% |
| Pretax Income | -583.493.837 | -585.310.825 | 0.3% |
| Net Income Common Stockholders | -573.598.190 | -529.022.761 | 8.4% |
| -- | -- | -- | |
| -- | -- | -- |